Baidu plans a Hong Kong IPO spin-off of AI chip unit Kunlunxin, boosting valuation as AI/Cloud growth accelerates. See why ...

Money managers increasingly fear that the forces now driving global growth in 2026 could reignite price pressures.

One is Ben Reitzes, an analyst at Melius Research, who upgraded Marvell Technology and Intel to Buy from Hold and assigning ...

Tirzepatide and semaglutide would have to drop their current net prices by 30.5% and 81.9%, respectively, to be cost-effective. Over a lifetime of use, tirzepatide could avert 45,609 obesity cases, 20 ...